European private equity firm Astorg has added Chris Benson as a London-based partner for its mid-cap fund and Daniel Pang as a New York-based managing director for its flagship fund within the healthcare team.
Benson will join in July, leading business services across Europe as well as coverage in the UK. Astorg’s mid-cap fund has previously invested in IQ-EQ, Normec, Fastmarkets, Third Bridge, Steliau and IPCOM.
Benson was most recently a director at global private equity firm Advent International, where he worked on the acquisitions and value creation of Seedtag, Evri, Hermes Germany, Williams Lea, Tag, V.Group, Nexi, Worldpay and Towergate, according to his LinkedIn profile.
As part of the healthcare team led by Judith Charpentier, Pang will identify and build healthcare businesses that “solve critical pain points in the B2B value chain”, according to a press statement, such as existing investments Clario and Corden Pharma.
Pang was most recently a principal in the healthcare group at Welsh, Carson, Anderson and Stowe. He has also worked at Arsenal Capital Partners and GTCR. Pang started his career in investment banking at Merrill Lynch, as part of the global mergers and acquisitions group.
